CD74 ELISA 试剂盒
-
- 抗原 See all CD74 ELISA试剂盒
- CD74 (HLA-DR-gamma (CD74))
-
适用
- 人
- 检测方法
- Colorimetric
- 实验类型
- Sandwich ELISA
- 检测范围
- 0.625 ng/mL - 40 ng/mL
- 最低检测浓度
- 0.625 ng/mL
- 应用范围
- ELISA
- 原理
- Human HLA class II histocompatibility antigen gamma chain ELISA Kit is an ELISA Kit against HLA class II histocompatibility antigen gamma chain.
- 样品类型
- Plasma, Serum
- Analytical Method
- Quantitative
- 灵敏度
- 0.38 ng/mL
- Featured
- Discover our best selling CD74 ELISA Kit
- Top Product
- Discover our top product CD74 ELISA Kit
-
-
- 应用备注
-
Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.
Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.
Standard Form: Lyophilized
- 板类型
- Pre-coated
- 限制
- 仅限研究用
-
- 储存条件
- 4 °C/-20 °C
- 储存方法
- Upon receipt, store the kit according to the storage instruction in the kit's manual.
- 有效期
- 6 months
-
- 抗原 See all CD74 ELISA试剂盒
- CD74 (HLA-DR-gamma (CD74))
- 别名
- HLA Class II Histocompatibility Antigen gamma Chain (CD74 产品)
- 别名
- DHLAG ELISA Kit, HLADG ELISA Kit, II ELISA Kit, Ia-GAMMA ELISA Kit, CLIP ELISA Kit, Ii ELISA Kit, INVG34 ELISA Kit, Iclp-1 ELISA Kit, iclp1 ELISA Kit, wu:fb11f09 ELISA Kit, wu:fb12a01 ELISA Kit, wu:fb13d06 ELISA Kit, wu:fk94e07 ELISA Kit, Iclp-2 ELISA Kit, cd74 ELISA Kit, iclp2 ELISA Kit, zgc:123161 ELISA Kit, CD74 molecule ELISA Kit, CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) ELISA Kit, CD74 molecule, major histocompatibility complex, class II invariant chain a ELISA Kit, CD74 molecule, major histocompatibility complex, class II invariant chain b ELISA Kit, CD74 ELISA Kit, Cd74 ELISA Kit, cd74a ELISA Kit, cd74b ELISA Kit
- 途径
- Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Negative Regulation of intrinsic apoptotic Signaling, Cancer Immune Checkpoints
-